![Omicron booster: UK becomes first nation to approve vaccine that targets two Covid-19 variants | CNN Omicron booster: UK becomes first nation to approve vaccine that targets two Covid-19 variants | CNN](https://media.cnn.com/api/v1/images/stellar/prod/220815081045-moderna-covid-booster-omicron-variant.jpg?c=original)
Omicron booster: UK becomes first nation to approve vaccine that targets two Covid-19 variants | CNN
![Covid autumn booster vaccine 2023: Everything you need to know - Department of Health and Social Care Media Centre Covid autumn booster vaccine 2023: Everything you need to know - Department of Health and Social Care Media Centre](https://healthmedia.blog.gov.uk/wp-content/uploads/sites/169/2023/08/Design-1.png)
Covid autumn booster vaccine 2023: Everything you need to know - Department of Health and Social Care Media Centre
![UK Volunteers to receive Moderna Omicron COVID-19 booster vaccine in study led by St George's, University of London - St George's University Hospitals NHS Foundation Trust UK Volunteers to receive Moderna Omicron COVID-19 booster vaccine in study led by St George's, University of London - St George's University Hospitals NHS Foundation Trust](https://www.stgeorges.nhs.uk/wp-content/uploads/2022/02/SGUL-Moderna-vaccine-trial.jpg)
UK Volunteers to receive Moderna Omicron COVID-19 booster vaccine in study led by St George's, University of London - St George's University Hospitals NHS Foundation Trust
![Safety and immunogenicity of seven COVID-19 vaccines as a third dose ( booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial - Safety and immunogenicity of seven COVID-19 vaccines as a third dose ( booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial -](https://www.thelancet.com/cms/attachment/966d70c5-8395-4ea2-9a35-94dc18f2f550/gr1.gif)